Skip to content

Digital Health Intervention Based on Artificial Intelligence to Support the Personalized Recovery of Long COVID Patients Affected by Fatigue (AIDA)

AIDA - A Digital Health Intervention Based on Artificial Intelligence to Support the Personalized Recovery of Long COVID Patients: Feasibility Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05483829
Acronym
AIDA
Enrollment
15
Registered
2022-08-02
Start date
2022-08-01
Completion date
2022-08-28
Last updated
2022-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Acute COVID-19 Syndrome

Keywords

Long COVID, mhealth, digital health, emotional health, behavioral intervention, mental wellbeing, mood disturbance, emotional adjustment

Brief summary

The AIDA feasibility study builds upon mental health and technology acceptance theoretical frameworks. It examines the feasibility of a mobile-based digital program to support patients with long covid affected by fatigue. The program Adhera ® Fatigue Self-management is adapted for long covid patients.

Detailed description

The study will explore the usability and engagement of a digital program designed for long covid patients affected by fatigue. The digital program relies on the Adhera® personalized digital health solution that includes personalized patient education and support, monitoring using psychometrics and wearables, and mental wellbeing exercises. The patients access the mobile solution via a mobile app. A total of 15 patients will be recruited and use the mobile solution for one month.

Interventions

BEHAVIORALAdhera® Fatigue for Long COVID program

Adhera® for the Long COVID program, which includes an application and a smartwatch, supported by digital health solution based on emotional and behavioral change techniques. Patient Adaptative Self-Management Content (e.g. psycho-educational content, activities for mental wellbeing, personalized motivational messages), and the personalization is based on Adhera® Health Recommender System. Wearable devices and the mobile app will be used to collect real-time data for 4 weeks to detect biometric and psychometric (patient-reported outcomes) information.

Sponsors

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
CollaboratorOTHER
Adhera Health, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Legal adults (older than 18) * Long COVID diagnosis within the last year * In possession of a compatible smartphone (Android OS v4.4 or higher) * Reporting any of these symptoms: * Fatigue * Dyspnea * Anxiety * Stress * Depression * Sleep disorder

Exclusion criteria

* Hospital admission during follow-up due to pathology not related to COVID-19 * Patients without digital literacy or who cannot use the mobile application. * Known severe psychiatric illness or cognitive impairment * Being pregnant (or suspected to be pregnant)

Design outcomes

Primary

MeasureTime frameDescription
Behavioral outcome: UsabilityAt week 4mHealth solution usability assessed with the System Usability Scale (SUS) questionnaire. SUS can range between 0 and 100 scores, with higher values representing higher usability.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026